<DOC>
	<DOCNO>NCT00875901</DOCNO>
	<brief_summary>This research study determine hypofractionated image guide radiation therapy ( hypoIGRT ) proton therapy good way treat early stage lung tumor patient surgery . HypoIGRT deliver high daily dos radiation short period time compare conventional radiation . This think deliver lethal dose radiation tumor convenient treatment complete within 2-3 week compare typical 7-8 week course conventional radiotherapy .</brief_summary>
	<brief_title>Proton Therapy Stage I Non-Small Cell Lung Cancer ( LU03 )</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Cobalt</mesh_term>
	<criteria>Pathologically confirm , biopsy cytology , nonsmall cell lung carcinoma diagnose within 3 month prior study enrollment . T1 , N0 , M0 T2 , N0 , M0 . At least 18 year old time consent . Adequate bone marrow function . Medically inoperable . Medically operable candidate allow refuse surgical resection . If patient large pleural effusion , must biopsy negative . Evidence distant metastasis ( M1 ) and/or nodal involvement ( N1 , N2 , N3 ) . Synchronous primary . T2 tumor &gt; 5 cm ; T3 , T4 primary tumor . Previous radiotherapy lung cancer . Concomitant local , regional , and/or systemic therapy radiotherapy . Active systemic , pulmonary , and/or pericardial infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Lung Cancer</keyword>
	<keyword>Stage I Non-Small Cell Lung Cancer</keyword>
	<keyword>Proton Radiation</keyword>
	<keyword>HypoIGRT</keyword>
</DOC>